ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,031Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 2094

$2.36M Total Retail Price of All Prescriptions

Rank: 7 out of 2094

813 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 813 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

3% of this provider’s 813 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

2% of this provider’s 25,002 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

45% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
OMEPRAZOLE 853 699 1 4
ZOLPIDEM TARTRATE 770 620 2 14
DIOVAN 737 612 3 13
DIOVAN HCT 727 635 4 28
AMLODIPINE BESYLATE 724 646 5 2
CRESTOR 713 574 6 15
NEXIUM 651 519 7 16
ATORVASTATIN CALCIUM 627 544 8 5
CARVEDILOL 555 525 9 19
METFORMIN HCL 554 469 10 8
LEVOTHYROXINE SODIUM 512 427 11 3
TRAMADOL HCL 504 403 12 33
SIMVASTATIN 430 367 13 1
LEVOFLOXACIN 413 313 14 70
GLIMEPIRIDE 402 344 15 31
LOVAZA 373 298 16 53
MELOXICAM 368 326 17 49
FUROSEMIDE 356 343 18 6
NAPROXEN 350 289 19 84
DONEPEZIL HCL 345 334 20 20
MECLIZINE HCL 341 288 21 103
PROAIR HFA 336 251 22 45
JANUVIA 311 290 23 35
SINGULAIR 301 231 24 64
LEVOCETIRIZINE DIHYDROCHLORIDE 290 225 25 169
METOPROLOL SUCCINATE 287 246 26 9
SERTRALINE HCL 286 272 27 26
DEXILANT 273 250 28 124
LYRICA 265 235 29 85
CLOTRIMAZOLE-BETAMETHASONE 264 232 30 91
NAMENDA 259 247 31 32
LOSARTAN POTASSIUM 254 240 32 17
TRILIPIX 242 176 33 156
VOLTAREN 241 210 34 109
LISINOPRIL 239 201 35 7
CLOPIDOGREL 233 210 36 22
ALENDRONATE SODIUM 227 205 37 30
BETAMETHASONE DIPROPIONATE 227 189 37 202
METOPROLOL TARTRATE 222 205 39 10
FLUTICASONE PROPIONATE 217 178 40 41
IBUPROFEN 217 167 40 73
PANTOPRAZOLE SODIUM 214 141 42 37
NASONEX 213 165 43 194
ADVAIR DISKUS 204 121 44 36
LIDODERM 203 154 45 59
PLAVIX 200 176 46 38
ONGLYZA 198 139 47 134
ESCITALOPRAM OXALATE 192 175 48 46
LOSARTAN-HYDROCHLOROTHIAZIDE 188 152 49 52
POTASSIUM CHLORIDE 187 172 50 24
GABAPENTIN 185 120 51 23
OXYCODONE-ACETAMINOPHEN 184 167 S2 52 40
MONTELUKAST SODIUM 182 153 53 128
HYDROCHLOROTHIAZIDE 181 153 54 12
CELEBREX 178 116 55 74
LIPITOR 171 155 56 39
BENICAR 156 125 57 108
PATANOL 153 107 58 198
RANITIDINE HCL 153 145 58 80
LISINOPRIL-HYDROCHLOROTHIAZIDE 152 109 60 55
LANSOPRAZOLE 150 121 61 144
PAROXETINE HCL 149 127 62 77
TRICOR 149 119 62 99
CYCLOBENZAPRINE HCL 146 88 R 64 115
ENDOCET 146 70 S2 64 88
PRAVASTATIN SODIUM 142 137 66 18
AZITHROMYCIN 130 101 67 27
ACTONEL 128 109 68 151
ALLOPURINOL 125 105 69 50
FAMOTIDINE 121 116 70 34
POLYETHYLENE GLYCOL 3350 116 97 71 75
TAMSULOSIN HCL 116 107 71 29
AMMONIUM LACTATE 116 104 71 185
IBANDRONATE SODIUM 108 94 74 140
AMLODIPINE BESYLATE-BENAZEPRIL 106 101 75 58
ENALAPRIL MALEATE 104 82 76 25
FENOFIBRATE 103 85 77 104
METHYLPREDNISOLONE 103 77 77 127
BENICAR HCT 103 78 77 133
JANUMET 102 82 80 86
CIPROFLOXACIN HCL 101 78 81 81
GLYBURIDE-METFORMIN HCL 100 84 R 82 94
ISOSORBIDE MONONITRATE ER 98 98 83 57
EXELON 96 95 84 111
RAMIPRIL 96 53 84 48
AMOX TR-POTASSIUM CLAVULANATE 94 61 86 107
WARFARIN SODIUM 93 54 87 11
ATENOLOL 92 56 88 21
EXFORGE 89 89 89 105
SPIRIVA 88 63 90 60
FEXOFENADINE HCL 87 77 91 191
ZETIA 86 72 92 79
METFORMIN HCL ER 83 74 93 67
DICLOFENAC SODIUM 82 75 94 168
AVELOX 79 64 95 300
MICARDIS 79 52 95 252
PROCTOZONE-HC 79 66 95 266
GLYBURIDE 78 59 R 98 95
LEXAPRO 77 60 99 180
NOVOLOG 77 62 99 116
CLOTRIMAZOLE 75 65 101 370
CIPRODEX 74 55 102 452
CYMBALTA 73 64 103 61
LUNESTA 73 73 103 293
INSULIN SYRINGE 71 54 105 143
BYSTOLIC 69 46 106 83
DESOXIMETASONE 68 49 107 320
GLIPIZIDE 67 61 108 82
DIGOXIN 67 47 108 51
VALSARTAN-HYDROCHLOROTHIAZIDE 63 56 110 225
ATELVIA 63 52 110 135
TEKTURNA 61 58 112 288
TORSEMIDE 61 49 112 118
MEGESTROL ACETATE 61 58 R 112 174
MEGACE ES 57 51 R 115 301
EVISTA 57 53 115 131
RENVELA 56 55 117 263
MICARDIS HCT 56 55 117 266
AMITIZA 56 56 117 239
ENABLEX 56 44 117 345
NITROGLYCERIN PATCH 55 52 121 101
LANTUS 54 54 122 66
DIVALPROEX SODIUM 54 43 122 69
CITALOPRAM HBR 53 35 124 47
SYNTHROID 53 45 124 44
GLIPIZIDE XL 53 49 124 122
FLECTOR 52 43 127 394
PRANDIN 52 52 127 125
LEVETIRACETAM 52 52 127 78
GLIPIZIDE ER 50 39 130 126
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.